A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist in obese and overweight patients: a high-dose study